UPDATE 2-Trevena's opioid painkiller fails to get FDA panel backing
October 11, 2018 at 16:28 PM EDT
Trevena Inc's opioid injection for managing acute pain failed to win the backing of an advisory panel to the Food and Drug Administration on Thursday, against the backdrop of opioid addiction in the United States reaching epidemic proportion.
